Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells
- 22 October 2008
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 176 (1) , 9-18
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Carbonyl Reductases: The Complex Relationships of Mammalian Carbonyl- and Quinone-Reducing Enzymes and Their Role in PhysiologyAnnual Review of Pharmacology and Toxicology, 2007
- Aldo-Keto Reductases and Bioactivation/DetoxicationAnnual Review of Pharmacology and Toxicology, 2007
- Carbonyl Reductases and Pluripotent Hydroxysteroid Dehydrogenases of the Short-chain Dehydrogenase/reductase SuperfamilyDrug Metabolism Reviews, 2007
- Multiplicity of Mammalian Reductases for Xenobiotic Carbonyl CompoundsDrug Metabolism and Pharmacokinetics, 2006
- Human Carbonyl Reduction Pathways and a Strategy for Their Study In VitroDrug Metabolism Reviews, 2004
- The aldo-keto reductase superfamily homepageChemico-Biological Interactions, 2003
- Structure-function aspects and inhibitor design of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)Molecular and Cellular Endocrinology, 2001
- Carbonyl reductaseChemico-Biological Interactions, 2000
- Induction of daunorubicin carbonyl reducing enzymes by daunorubicin in sensitive and resistant pancreas carcinoma cellsBiochemical Pharmacology, 1996
- Immunohistochemical localization of carbonyl reductase in human tissues.Journal of Histochemistry & Cytochemistry, 1992